| 47 | | * [http://www.cgl.ucsf.edu/chimera/data/hiv-core-june2011/hivcore.html HIV Capsid] - Illustrates composite model building of HIV conical core particle. Capsid protein interfaces highly conserved drug target (June 2011 PNAS [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136285/?tool=pubmed paper]) |
| | 47 | * [http://www.cgl.ucsf.edu/chimera/data/hiv-core-june2011/hivcore.html HIV Capsid] - Illustrates composite model building of HIV conical core particle. |
| | 48 | * Some capsid protein interfaces have few viable multisite mutations that enable drug resistance. June 2011 PNAS [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136285/?tool=pubmed paper]. This article is quite theoretical but does compare results to HIV resistant patients' cyto-toxic lymphocite HLA epitopes that support their conclusions. |
| | 49 | * New Approaches for Antiviral Targeting of HIV Assembly, JMB July 2011 review, [http://www.ncbi.nlm.nih.gov/pubmed/21762804 paper]. Describes several capsid assembly inhibitors or stablizers/destabilizers. Only one (Bevirimat) reached clinical trials with only some patients responding favorably. Article emphasizes escape mutant issues. |